* NOVO NORDISK TO ACQUIRE CORVIDIA THERAPEUTICS AND EXPAND PRESENCE IN CARDIOVASCULAR DISEASE
* UNDER TERMS OF AGREEMENT, NOVO NORDISK WILL ACQUIRE ALL OUTSTANDING SHARES OF CORVIDIA THERAPEUTICS FOR AN UPFRONT PAYMENT OF 725 MILLION US DOLLARS IN CASH
{iframe}https://www.reuters.com/article/brief-novo-nordisk-to-acquire-corvidia-t/brief-novo-nordisk-to-acquire-corvidia-therapeutics-idUSFWN2DO09X{/iframe}